Loading…
KOD · NASDAQ · Biological Products, (No Diagnostic Substances)
Next results expected Nov 11, 2026 (Q3 2026). Dates can move until the company confirms them.
Headlines link to the original article. Lists and “should you buy” pieces are left out. Coverage is not a recommendation.